or Try an Advanced Search...

    Technical Analysis for EVGN - Evogene

    Grade Last Price % Change Price Change
    F 2.24 -1.75% -0.04
    EVGN closed down 1.75 percent on Friday, November 1, 2024, on 1.97 times normal volume. The bears made the stock sink to a new 52-week low.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical EVGN trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    New 52 Week Low Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    20 DMA Resistance Bearish -1.75%
    50 DMA Resistance Bearish -1.75%
    180 Bearish Setup Bearish Swing Setup -1.75%
    New Uptrend Bullish -1.75%
    Volume Surge Other -1.75%
    Older End-of-Day Signals for EVGN ...

       Recent Intraday Alerts

    Alert Time
    Gap Down Partially Closed 1 day ago
    Gap Down Closed 1 day ago
    Reversed from Down 1 day ago
    Lower Bollinger Band Support 1 day ago
    Gapped Down (Partial) 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EVGN Chart by TradingView
    Basic chart:

    Profile

    Evogene Description

    Evogene Ltd., a plant genomics company, engages in the development of enhanced plant traits through the use of plant genomics. It primarily focuses on the development of food crops, including corn, soybean, cotton, canola, rice, and wheat, as well as castor for the production of biofuel. The company's technologies include ATHLETE for gene discovery; Gene2Product for enhancing trait efficacy and probability of successful development of biotechnology seed products; and EvoBreed for breeding enhancement. It holds granted or pending patents to approximately 3,000 novel genes. The company has collaboration agreements with Bayer CropScience; Biogemma; Centre de Cooperation Internationale en Recherche Agronomique pour le Development; DuPont; Monsanto Company; Rahan Meristem (1998) LTD; Rasi Seeds (P) Ltd.; Syngenta; Vilmorin; Viterra; and Zeraim Gedera for the development of various products and provision of plant enhancement solutions. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Genomics Crops Soybean Wheat Biofuel Cotton Canola Oil Rehovot Monsanto Seed Products

    Is EVGN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
    Oct 29 Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
    Oct 8 Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
    Sep 30 Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
    Aug 23 Evogene prices $5.5M direct offering
    Aug 23 Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
    Jul 31 Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil
    Jul 23 Evogene to effect 1-for-10 reverse stock split
    Jul 23 Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
    Jul 17 ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
    See more EVGN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.4
    52 Week Low 2.02
    Average Volume 311,446
    200-Day Moving Average 5.89
    50-Day Moving Average 2.79
    20-Day Moving Average 2.48
    10-Day Moving Average 2.44
    Average True Range 0.30
    RSI (14) 37.89
    ADX 24.08
    +DI 21.78
    -DI 23.25
    Chandelier Exit (Long, 3 ATRs) 2.17
    Chandelier Exit (Short, 3 ATRs) 2.92
    Upper Bollinger Bands 2.80
    Lower Bollinger Band 2.16
    Percent B (%b) 0.12
    BandWidth 25.83
    MACD Line -0.16
    MACD Signal Line -0.16
    MACD Histogram 0.0048
    Fundamentals Value
    Market Cap 113.23 Million
    Num Shares 50.5 Million
    EPS -0.47
    Price-to-Earnings (P/E) Ratio -4.77
    Price-to-Sales 6.69
    Price-to-Book 2.07
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.77
    Resistance 3 (R3) 2.76 2.57 2.69
    Resistance 2 (R2) 2.57 2.43 2.58 2.66
    Resistance 1 (R1) 2.40 2.35 2.49 2.42 2.63
    Pivot Point 2.21 2.21 2.25 2.22 2.21
    Support 1 (S1) 2.05 2.08 2.13 2.06 1.85
    Support 2 (S2) 1.86 1.99 1.86 1.82
    Support 3 (S3) 1.69 1.86 1.79
    Support 4 (S4) 1.71